- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0100
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glucocorticoid-induced osteoporosis: an update ; volume:61 ; number:1 ; day:24 ; month:4 ; year:2018 ; pages:7-16 ; date:7.2018
Endocrine ; 61, Heft 1 (24.4.2018), 7-16, 7.2018
- Urheber
-
Compston, Juliet
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12020-018-1588-2
- URN
-
urn:nbn:de:101:1-2018082111283267088349
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Compston, Juliet
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glucocorticoid induced osteoporosis : 12 tables
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis
Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
Glucocorticoid induced osteoporosis : 12 tables
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis
Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
Glucocorticoid induced osteoporosis : 12 tables
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis